Evidence map›Paper›PMID 42278629›Full record

ArticleInternational journal of molecular sciences2026

Population-Specific Exploration of

Nor Elhouda Nacer, Soumia Missoum, Houssem Eddine Ouarhlent, Seddam Hares, Asma Ribouh, Ghania Belaaloui

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nor Elhouda NacerLaboratory of Acquired and Constitutional Genetic Diseases (MAGECA), Faculty of Medicine, University of Batna 2, Batna 05000, Algeria.
Soumia MissoumFaculty of Medicine, University of Batna 2, Batna 05000, Algeria.
Houssem Eddine OuarhlentFaculty of Medicine, University of Batna 2, Batna 05000, Algeria.
Seddam HaresLaboratory of Acquired and Constitutional Genetic Diseases (MAGECA), Faculty of Medicine, University of Batna 2, Batna 05000, Algeria.
Asma RibouhBiotechnology Research Center (CRBt), Constantine 25000, Algeria.
Ghania BelaalouiLaboratory of Acquired and Constitutional Genetic Diseases (MAGECA), Faculty of Medicine, University of Batna 2, Batna 05000, Algeria.ORCID 0000-0003-0431-7286

Funding

Ministry of Higher Education and Scientific Research N/A
6 · The paper itself

Abstract

Acute renal allograft rejection (AR) is immune-mediated. Recent evidence highlights some microRNAs as immune modulators. Few and conflicting studies have studied the impact of the

Indexed as

Graft RejectionKidney TransplantationMicroRNAsPolymorphism, Single NucleotideAcute DiseaseAdultCase-Control StudiesCross-Sectional StudiesFemaleGenetic Predisposition to DiseaseGenotypeHumansMaleMiddle AgedMicroRNAsMIRN146 microRNA, humanacute renal rejectionHLA-A* mismatchMIR146Apost-transplant infectionsrs2910164

Identifiers

PMID42278629
PMCPMC13257254

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.